Efficacy and safety of bevacizumab in Turkish patients with metastatic and recurrent cervical cancer

Creative Commons License

Ercelep O., Tataroglu D., Ozcelik M., Surmeli H., Degirmenci M., Inanc M., ...More

TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, vol.17, no.2, pp.123-127, 2020 (ESCI) identifier identifier identifier


Objective: To evaluate the efficacy of bevacizumab a monoclonal, antivascular endothelial growth factor antibody in combination with cytotoxic chemotherapy in Turkish patients with recurrent and metastatic cervical cancer.